SCHEMBL23618158

SCHEMBL23618158

Cc1sc(N)nc1-c1cccc2c1=CCCC=2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPL P40238 3/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CD274 Q9NZQ7 1/20 0.38
▸ HTR6 P50406 2/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ LTK P29376 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ LIMK1 P53667 1/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ CLK4 Q9HAZ1 1/20 0.37
▸ DYRK1B Q9Y463 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ ADORA1 P30542 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28902429 0.72 MPL (0.55) MPLSMN1; SMN2CD274HTR6CHEK1
SCHEMBL6385170 0.71 HTR6 (0.55) MPLSMN1; SMN2HTR6CHEK1DAPK3
SCHEMBL23618154 0.71 CD274 (0.56) MPLSMN1; SMN2CD274ADORA1ALDH1A1
SCHEMBL30256985 0.69 MYC (0.56) MPLSMN1; SMN2HTR6CHEK1DAPK3
SCHEMBL4872467 0.66 MPL (1.00) MPLSMN1; SMN2CD274HTR6DRD2
SCHEMBL27843646 0.66 NOS1 (0.62) MPLSMN1; SMN2CD274HTR6DRD2
SCHEMBL23610344 0.65 HTR6 (0.49) MPLSMN1; SMN2CD274HTR6CHEK1
Hydrochloric Acid SCHEMBL4868732 0.65 MPL (0.97) MPLSMN1; SMN2CD274HTR6DRD2
SCHEMBL330423 0.64 SMN1; SMN2 (0.64) MPLSMN1; SMN2CD274ALDH1A1KDM4E
SCHEMBL10811711 0.64 MPL (0.44) MPLSMN1; SMN2CD274HTR6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205275-A1 NEUROPROTECTIVE COMPOSITIONS AND METHODS OF USING THE SAME GAP43, NLN, SMN1; SMN2 MPL 4766/4885SMN1; SMN2 3/4885CD274 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback